Follow the Biovica International AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Biovica International AB has logged 13 public disclosures. Market capitalisation: €151.2m. The latest transaction was reported on 22 July 2026 (Purchase). Among the most active insiders: Theis Kipling. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€269,626
12 ops.
Buy Volume
n/a
n/a
Sell Volume
39Σ signal
Buys €269,626n/a Sells
Fundamental score
Ranked 24,183 of 28,717 companies
27.3
score / 100
Value
5
Quality
50
FCF yld-46%
Earn yld-51%
EV/EBITDA·
ROE-108%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.